Status:
COMPLETED
Primary Angle Closure Glaucoma and Aqueous Dynamics
Lead Sponsor:
Guy's and St Thomas' NHS Foundation Trust
Conditions:
Primary Angle Closure
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The aim of the study is to determine which is the best treatment for people with cataract and primary angle closure (PAC).In PAC, apposition of the iris tissue to the drainage channels (Trabecular Mes...
Eligibility Criteria
Inclusion
- Age ≥ 21 years.
- Diagnosis of PAC or PACG. PACG is defined as glaucomatous optic neuropathy in the opinion of a fellowship-trained glaucoma specialist, together with an IOP \> 21mmHg on at least one occasion, and reproducible visual field defect (using the 24-2 test pattern on a Humphrey Field Analyser). PAC has all the above characteristics except for the visual field defect.
- More than 90 degrees of PAS (not necessarily contiguous).
- Lens opacity deemed sufficient to be causing decreased vision in the opinion of the supervising consultant (KSL).
- Ability to give informed consent.
Exclusion
- Previous intraocular surgery or keratorefractive surgery.
- Previous eye trauma resulting in documented damage to the drainage angle (such as angle recession).
- History of uveitis.
- For patients on warfarin, INR \>3.0 on day of surgery.
- Anterior segment neovascularisation.
- Chronic use of topical or systemic steroids.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00719290
Start Date
July 1 2008
End Date
August 1 2015
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Thomas' Hospital
London, United Kingdom, SE1 7EH